CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nanjing King-Frind Bchmcl Phrmctcl C Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nanjing King-Frind Bchmcl Phrmctcl C Ltd
No. 16 Xuefu Road
High-tech Industrial Development Zone
Phone: +86 2586990789p:+86 2586990789 NANJING, JNG  210061  China Ticker: 603707603707
Business Summary
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of heparin-related products. The Company's main products include standard heparin raw materials, low molecular weight heparin raw materials and their preparations, such as heparin sodium raw materials, heparin sodium, enoxaparin sodium injection, dalteparin sodium injection and Naqu Heparin Calcium Injection. The Company mainly exports its products to the United States and European countries.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager YongqunTang 49 10/26/2017 10/26/2017
Finance Director XiaojieQian 44 4/1/2022 4/1/2022
Deputy General Manager, Secretary of the Board, Director XiweiHuang 54 4/27/2022
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Kindos Pharmaceuticals Co., Ltd. No.8-9, Kexin Road Chengdu China
Meitheal Pharmaceuticals, Inc. 8700 W. Bryn Mawr, Suite 600S Chicago IL United States

Business Names
Business Name
603707
Hong Kong King-Friend Industrial Company
KINDOS PHARMACEUTICALS CO., LTD.
Meitheal Pharmaceuticals, Inc.
Sagent (China) Pharmaceuticals Co., Ltd.
YUSIMRY

General Information
Number of Employees: 1,451 (As of 12/31/2023)
Outstanding Shares: 1,615,634,520 (As of 9/30/2024)
Shareholders: 19,409
Stock Exchange: SHA
Fax Number: +86 2586990701


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024